Description
The wound care industry is an incredibly diverse and highly competitive arena that is ever-changing. Kalorama Information feels that the market will continue to expand over the long term due to an aging population, longer life expectancies, and an increasing number of sicker patients across all care settings.
This report, Advanced Wound Care Markets, provides breakouts of the market by category, including the following:
- Skin Ulcers (Management, Moist Dressing, Negative Pressure Wound Therapy, Biological Dressings, Pressure Relief)
- Burns Wound Care Market (Anti-Infectives, Management, Moist Dressing, Biological Dressings, Pressure Relief)
- Surgical and Trauma Wounds (Wound Closure, Anti-Infectives, Moist Dressing, Biological Dressing, Miscellaneous Surgical and Trauma Wound Treatments)
The emerging generation of wound care products and technologies is well-positioned to capitalize on this growth. Besides the always-improving synthetic dressing materials, newer technologies in wound treatment include the xenogeneic tissue scaffold, bilayered human dermal substitutes, recombinant growth factors, endoscopic subfascial ligation of venous perforators, and endovascular arterial repair techniques. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes.
To capture this market, Kalorama breaks out the wound market further not only by application but by type of product, with further subsegmentation within product categories:
- Moist Dressings Segment (Alginates, Hydrocolloids, Hydrogels, Films, Foams)
- Management Segment (Cleansing, Debridement, Tapes, Dry Dressings, Silver Dressings)
- Biological Dressings Segment (Artificial Skins and Collagen Products)
- Wound Closure (Sutures, Staplers and Staples; Tissue Adhesives, Sealants, and Glues)
In the short term, there will be more ebb and flow in the industry due to changes in reimbursement, contract bidding, mergers and acquisitions, and changes in the delivery of health care. Patients have more complex coexisting illnesses such as diabetes, heart failure, obesity, pulmonary and vascular diseases, immobility issues and chronic wounds. These factors are all influenced by future demographic trends, economic uncertainty, the impact of health care reform, increasing numbers of uninsured patients, reimbursement pressures from third party payers, continuing shortage of nurses and physicians and increasing technology and supply costs.
Issues and trends shaping the industry that are discussed in the report include:
- World Demographics
- Scars
- Honey Treatment
- Healthcare Reimbursement by Country
- Electronic Medical Records
- Mesenchymal Stem Cells
- Telemedicine and Wound Care
- Vitamin D
- Apps for Wound Care
- Obesity and Wound Healing
- Non-Payment Events
- Evidence Based Wound Care
- Silver Toxicity
- Home Care
- Competitive Bidding Contracts
- Medical Device Tax
- Cost Considerations
- Surgical Infection
- Wound Care Technologies
- Wound Care Clinics
The information and analysis presented in this report are based on extensive surveys of senior management in the wound care market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct over 100 face to face, telephone and email interviews with industry executives and product managers to validate and obtain expert opinion on current and future trends in the wound care industry. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.
- 3M Health Care
- ABL Medical, LLC
- ACELL, INC
- Alliqua Biomedical, Inc
- Amniox Medical
- Angelini Pharma, Inc
- Argentum Medical, LLC
- ArjoHuntleigh
- Arobella Medical, LLC
- Baxter Bioscience
- B. Braun/Aesculap, Inc.
- BSN medical
- Celleration
- Coloplast A/S
- ConvaTec, Ltd.
- Covidien, Ltd
- CryoLife, Inc.
- Curaline, Inc
- Derma Sciences
- DeRoyal Industries
- EHOB, Inc
- Ethicon, Inc
- GlaxoSmithKline Plc
- Hartmann Group
- Hill-Rom Company, Inc.
- Hollister Wound Care LLC
- Integra Life Sciences
- Johnson & Johnson
- Kinetic Concepts, Inc. (KCI)
- LifeBond Ltd
- Lohmann and Rauscher GmbH
- Marine Polymer Technologies, Inc.
- Medline Industries
- MiMedx
- Molnlycke HealthCare
- MPM Medical, Inc
- Oculus Innovative Sciences, Inc
- Organogenesis, Inc
- Osiris Therapeutics, Inc
- Pfizer, Inc.
- Shire Plc
- Smith & Nephew, Plc
- Soluble Systems, LLC
- Southwest Technologies
- Spiracur, Inc
- SteadMed Medical
- Stryker Corp
